{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:35:39Z","timestamp":1791117339706,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.ucl.2007.09.012","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T14:16:23Z","timestamp":1196864183000},"page":"109-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"title":["Inflammation and Benign Prostatic Hyperplasia"],"prefix":"10.1016","volume":"35","author":[{"given":"J. Curtis","family":"Nickel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ucl.2007.09.012_bib1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"Berry","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"282","author":"Krieger","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ucl.2007.09.012_bib3","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-5347(05)64572-7","article-title":"Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the NIH chronic prostatitis cohort (CPC) study","volume":"168","author":"Schaeffer","year":"2002","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2007.09.012_bib4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.ju.0000082252.49374.e9","article-title":"Leukocytes and bacteria in men with chronic prostatitis\/chronic pelvic pain syndrome compared to asymptomatic controls","volume":"170","author":"Nickel","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib5","first-page":"2014","article-title":"Prostate histopathology and the chronic prostatitis\/chronic pelvic pain syndrome: a prospective biopsy study","volume":"162","author":"True","year":"1999","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib6","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/01.ju.0000139320.78673.2a","article-title":"Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial","volume":"172","author":"Andriole","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib7","first-page":"896","article-title":"Examination of the relationship between symptoms of prostatitis and histologic inflammation: baseline data from the REDUCE chemoprevention trial","volume":"178","author":"Nickel","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2165\/00002512-200320150-00004","article-title":"Chronic prostatitis\/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment","volume":"20","author":"Pontari","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ucl.2007.09.012_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0090-4295(98)00034-X","article-title":"Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men","volume":"51","author":"Roberts","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2007.09.012_bib10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0022-5347(05)66541-X","article-title":"Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index","volume":"165","author":"Nickel","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0090-4295(98)00636-0","article-title":"Distinguishing chronic prostatitis and benign prostatic hyperplasia symptoms: results of a national survey of physician visits","volume":"53","author":"Collins","year":"1999","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2007.09.012_bib12","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0022-5347(05)65301-3","article-title":"Prevalence and correlates of prostatitis in the health professionals follow-up study cohort","volume":"167","author":"Collins","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib13","first-page":"542","article-title":"Impact of post-ejaculatory pain in men with category III chronic prostatitis\/chronic pelvic pain syndrome","volume":"172","author":"Shoskes","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.ucl.2007.09.012_bib14","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/01.ju.0000067940.76090.73","article-title":"Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms","volume":"169","author":"Vallancien","year":"2003","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.ucl.2007.09.012_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0895-4356(98)00044-4","article-title":"Sexual dysfunction in men with lower urinary tract symptoms","volume":"51","author":"Frankel","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ucl.2007.09.012_bib16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1136\/bmj.324.7345.1059","article-title":"Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomized control trial","volume":"324","author":"Brookes","year":"2002","journal-title":"Br Med J"},{"key":"10.1016\/j.ucl.2007.09.012_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2003.08.015","article-title":"Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7)","volume":"44","author":"Rosen","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1464-410X.2005.05341.x","article-title":"Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH","volume":"95","author":"Nickel","year":"2005","journal-title":"BJU Int"},{"issue":"Suppl 4","key":"10.1016\/j.ucl.2007.09.012_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0022-5347(18)31707-5","article-title":"Association between prostatitis and development of benign prostatic hyperplasia","volume":"177","author":"St. Sauver","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0022-5347(17)56980-3","article-title":"Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study","volume":"121","author":"Kohnen","year":"1979","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2007.09.012_bib21","first-page":"1","article-title":"Prostatic inflammation in benign prostatic hyperplasia\u2014the third component?","volume":"1","author":"Nickel","year":"1994","journal-title":"Can J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1464-410X.1971.tb12050.x","article-title":"Chronic prostatitis in benign prostatic hyperplasia","volume":"43","author":"Odunjo","year":"1971","journal-title":"Br J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1464-410x.1999.00352.x","article-title":"Asymptomatic inflammation and\/or infection in benign prostatic hyperplasia","volume":"84","author":"Nickel","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2007.09.012_bib24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1464-410x.2001.02193.x","article-title":"Consensus development of a histopathological classification system for chronic prostatic inflammation","volume":"87","author":"Nickel","year":"2001","journal-title":"BJU Int"},{"issue":"Suppl 4","key":"10.1016\/j.ucl.2007.09.012_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-5347(18)30363-X","article-title":"The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial","volume":"177","author":"Nickel","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.ju.0000161598.24740.34","article-title":"Benign prostatic hyperplasia cell line viability and modulation of JM-27 by Doxazosin and Ibuprofen","volume":"174","author":"Minnery","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.eururo.2004.08.024","article-title":"Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)","volume":"47","author":"Di Silverio","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib28","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1097\/01.ju.0000140503.11467.8e","article-title":"Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action","volume":"172","author":"Buck","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib29","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1097\/01.ju.0000133655.71782.14","article-title":"Molecular and cellular pathogenesis of benign prostatic hyperplasia","volume":"172","author":"Lee","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.exger.2004.12.008","article-title":"Benign prostatic hyperplasia: age-related tissue-remodeling","volume":"40","author":"Untergasser","year":"2005","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.ucl.2007.09.012_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.mou.0000193368.91823.1b","article-title":"Could inflammation be a key component in the progession of benign prostatic hyperplasia?","volume":"16","author":"Kramer","year":"2006","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib32","first-page":"96","article-title":"Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia","volume":"66","author":"Theyer","year":"1992","journal-title":"Lab Invest"},{"key":"10.1016\/j.ucl.2007.09.012_bib33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0022-5347(17)34998-4","article-title":"Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia","volume":"151","author":"Steiner","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/pros.10084","article-title":"Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation","volume":"52","author":"Kramer","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.ucl.2007.09.012_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/pros.10020","article-title":"Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate","volume":"49","author":"Handisurya","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.ucl.2007.09.012_bib36","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.LAB.0000081388.40145.65","article-title":"Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue","volume":"83","author":"Steiner","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.ucl.2007.09.012_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pros.10317","article-title":"Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer","volume":"58","author":"Konig","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.ucl.2007.09.012_bib38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/pros.20061","article-title":"Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium","volume":"61","author":"Wang","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.ucl.2007.09.012_bib39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/pros.10365","article-title":"Down-regulation of macrophage inhibitory cytokine-1\/prostate derived factor in benign prostatic hyperplasia","volume":"59","author":"Kakehi","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.ucl.2007.09.012_bib40","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/01.ju.0000149130.06055.f2","article-title":"The healthy rat prostate contains high levels of natural killer-like cells and unique subsets of CD4+ helperinducer T cells: implications for prostatitis","volume":"173","author":"Vykhovanets","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2007.09.012_bib41","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","article-title":"Is benign prostatic hyperplasia (bph) an immune inflammatory disease?","volume":"51","author":"Kramer","year":"2007","journal-title":"Eur Urol"},{"issue":"Suppl 2","key":"10.1016\/j.ucl.2007.09.012_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1464-410X.2006.06098.x","article-title":"Definition of at-risk patients: baseline variables","volume":"97","author":"Roehrborn","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2007.09.012_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/0962935031000097745","article-title":"Malondialdehyde in benign prostatic hypertrophy: a useful marker?","volume":"12","author":"Merendino","year":"2003","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ucl.2007.09.012_bib44","first-page":"43","article-title":"Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the third national health and nutrition examination survey (NHANES III)","volume":"52","author":"Rohrmann","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.ucl.2007.09.012_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/pros.20051","article-title":"Interleukin-8 exression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia","volume":"60","author":"Castro","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.ucl.2007.09.012_bib46","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.eururo.2006.07.016","article-title":"Seminal plasma cytokines and chemokines in prostate inflammation: interleukin-8 as a predictive biomarker in chronic prostatitis\/chronic pelvic pain syndrome and benign prostatic hyperplasia","volume":"51","author":"Penna","year":"2007","journal-title":"Eur Urol"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014307000973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014307000973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:19:48Z","timestamp":1758806388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014307000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0094014307000973"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2007.09.012","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation and Benign Prostatic Hyperplasia","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2007.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}